-
Most Recent
Search Results
240 results for CTX
AI Is Minting New Billionaires – Here’s How to Join Them
More AI also equals more billion-dollar tech companies… and, thanks to their high valuations, more billionaires. And I want to teach you how to stay…
Wall Street’s AI Rubicon: Jobs Crack, Stocks Split – Go All-In on AI
We’ve crossed a historic line in markets and the workplace — an “AI Rubicon” — and the only winning move now is to go all-in…
Builder Pulte Breaking Out
New buy signals could be telling us that PHM could breakout from a long-term base.
CRSP Stock: The Good News Goosing CRISPR Therapeutics Shares Today
Shares of CRSP stock are rising on Friday after CRISPR Therapeutics provided a positive business update regarding its leading drug candidate.
CRISPR Therapeutics Rallies as Gene Stocks Get Hot Again
CRSP is testing its gene editing therapies in sicke cell disease and cancer. These therapies could eventually boost CRSP stock.
CRISPR Therapeutics Stock Looks Like a Long-Term Biotech Winner
Gene editing has the potential to revolutionize medicine. With CRISPR Therapeutics leading the way, CRSP stock should benefit.
The Next Big Thing After AI? 3 Sleeper Stocks to Buy Before the Boom
These three sleeper stocks could deliver massive gains if their cutting-edge technologies take off in the coming years.
Crispr Therapeutics News: CRSP Stock Slides 12% on Trial Death
Crispr Therapeutics (CRSP) news for Wednesday includes a patient’s death during a recent drug trial dropping CRSP stock down.
Updated Clinical and Financial Data Make the Case for CRISPR Therapeutics
Looking for a terrific value in the biotechnology space? It doesn’t get much better than CRSP stock, which just entered a buy zone.
Why Is Cingulate (CING) Stock Up 72% Today?
Cingulate (CING) stock is on the rise Friday after releasing positive data concerning its ADHD treatment, which is in a Phase 3 trial.
CRISPR Therapeutics Is One of Today’s Best Biotech Value Investments
Don’t let the downtrend in CRSP stock fool you; the company is still making headway in advancing potentially life-changing therapeutics.
The “Hypergrowth” That’s Just Beginning for This Red-Hot Medical Trend
We talk a lot here about getting into unstoppable and explosive trends early, while stock prices are still cheap and consumer sentiment is just beginning…
Rags to Riches: 3 Gene Editing Stocks That Could Make Early Investors Rich
Gene editing is a game-changer, creating substantial opportunities for some of the leading gene editing stocks.
Consider Adding New Positions in U.S. Cannabis Stocks
It’s no secret Matt McCall is searching for emerging trends. This week, he discusses cannabis stocks and a breakthrough biotech therapy.
Why NOW Is the Time to Buy Gene Therapy Stocks
Over the long term, gene therapy stocks will head higher and the last few weeks’ of headlines show investors why.
Why Is Cingulate (CING) Stock Up 160% Today?
Cingulate (CING) stock is rallying sharply after Nasdaq agreed to hold a hearing regarding its previous decision to delist the shares.
After Soaring to New Highs, Crispr Therapeutics AG Stock Ripe for a Fall
Although Crispr’s gene splicing techniques are revolutionary, the rally in CRSP stock is coming to an end as investors question its valuation.
1 – 10 of 240 results
